Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Shares Issued: 2021

Historic Shares Issued for Janux Therapeutics (JANX) over the last 1 years, with Dec 2021 value amounting to $204.2 million.

  • Janux Therapeutics' Shares Issued fell 45.62% to $901,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $3.3 million, marking a year-over-year increase of 37.87%. This contributed to the annual value of $204.2 million for FY2021, which is N/A change from last year.
  • Janux Therapeutics' Shares Issued amounted to $204.2 million in FY2021.
  • In the past 5 years, Janux Therapeutics' Shares Issued ranged from a high of $204.2 million in FY2021 and a low of $204.2 million during FY2021.
  • Its 1-year average for Shares Issued is $204.2 million, with a median of $204.2 million in 2021.